1. Compare the efficacy of "Tetracycline combined with levofloxacin quadruple therapy", "standard tincture quadruple therapy" and "amoxicillin combined with levofloxacin quadruple therapy" on the second line of Helicobacter pylori sterilization. 2. To investigate the drug resistance of Helicobacter pylori and the host genotypes of CYP2C19 and IL-1B-511 on the sterilizing effect of three second-line Helicobacter pylori.
The "standard tincture quadruple therapy" and the "proton pump inhibitor combined with fluoroquinolone and amoxicillin triple therapy" recommended by the 5th Mazdock-Florence Consensus Conference on the second line of Helicobacter pylori treatment The sterilization rate is not ideal (less than 80%). Recently, we have developed a "Tetracycline combined with levofloxacin quadruple therapy" for first-line treatment failure of H. pylori infection, with a relatively high sterilization rate (\> 95%). A randomized controlled trial confirmed that the elimination rate of "Tetracycline combined with levofloxacin quadruple therapy" was better than "proton pump inhibitor combined with fluoroquinolone" after "standard triple therapy" and "non-tank tetratherapy" sterilization failure. Triple therapy with amoxicillin.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
240
Tetracycline combined with levofloxacin quadruple therapy
standard tincture quadruple therapy
amoxicillin combined with levofloxacin quadruple therapy
Kaohsiung Medical University Hospital
Kaohsiung City, Taiwan
RECRUITINGthe rate of Helicobacter pylori
evalute eradication outcome by 13C urea breath test
Time frame: 6 week after finish study drugs
genotype analysis
CYP2C19 genotype, IL-1B-511 genotype
Time frame: 2 weeks after finishing study drgus
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.